Home Administrative Billing & Reimbursement BlueCard® Health and Wellness Medical PEAR portal Pharmacy Products Quality Management

Expanded coverage of Shingrix for Independence commercial members

September 13, 2021

Independence has expanded its coverage of Shingrix for Commercial members. As of July 26, 2021, the Shingrix vaccine is considered medically necessary for individuals 18 years and older who are or will be at increased risk of herpes zoster due to immunodeficiency or immunosuppression caused by known disease or therapy. A cost share may apply based on member benefits.

Shingrix is covered as a preventive service for individuals 50 years or older regardless of whether they experienced a prior episode of herpes zoster or received Zostavax vaccine. It is also considered a preventive service for individuals 50 years or older with chronic medical conditions unless their condition constitutes a contraindication.

Please read the Medical Policy Bulletin for background, eligible procedure codes, and links to impacted policies. 


This content was prepared for the Provider News Center and may not be reproduced in any way without the express written permission of Independence Blue Cross. Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association.
Connect with us     Facebook     Twitter     Flickr     YouTube     Walk the Talk    Independence Pinterest    Independence LinkedIn    Independence Instagram Site Map        Anti-Fraud        Privacy Policy        Legal        Disclaimer
© 2023 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.